News

$32 million available to support vital translational health research

5 September 2019 Applications open 2 October 2019 & close 27 November 2019 The Morrison Government is opening the door for Australian researchers through a $32 million investment that will support innovative solutions to the nation’s most pressing…

The Social Costs of Delaying Effective Cancer Treatment Using CAR-T Immunotherapy

5 September 2019 CAR-T therapy can save lives and boost benefits to society … if it’s delivered promptly, says Cartherics CEO and Executive Director, Alan Trounson Using the tools of biotechnology and immunology to help transforming cancer from…

Companies urged to help with information on RDTI

3 September 2019 AusBiotech is commissioning research to quantify the additionality and spill-over effects of the R&D Tax Incentive (RDTI) and urgently calls on companies to help with information. Full article here.  

Australia’s National Digital Health Survey is open!

3 September 2019 Together we can transform the digital health sector in Australia; simply click the button below  As Australia’s only dedicated provider of digital health commercialisation support, ANDHealth is seeking input from digital health innovators and companies…

NRMRC Investigator Grants 2019 Outcomes: Factsheet

3 September 2019 Funding outcomes were recently announced for the new Investigator Grant scheme from the National Health and Medical Research Council (NHMRC). As the national peak body for entire health and medical research pipeline, we give our…

Better, easier, safer services to be achieved through public data sharing reform

3 September 2019 Minister for Government Services, Stuart Robert, today announced a major milestone in the Morrison Government’s commitment to improve government service delivery. A discussion paper outlining proposed landmark public data sharing reforms has been released with…

GTG New Board Appointment

2 September 2019 Genetic Technologies is pleased to announce the appointment of Nick Burrows as Non-Executive Director to the board. Mr Burrows is a contemporary independent Non-Executive Director across the Listed, Government and Private sectors with significant expertise…

IDT Secures its first Medicinal Cannabis Manufacturing Permit from the Office of Drug Control

27 August 2019 IDT Australia Limited (ASX: IDT) is pleased to announce that the Department of Health – Office of Drug Control has granted the Company its first Medicinal Cannabis Manufacturing Permit under the Narcotic Drugs Act 1967.…

Positive results with Targeted DEP® using antibody fragment in human ovarian cancer model – Starpharma

29 August 2019 Melbourne, Australia: Starpharma today announced that treatment with a novel HER-2 Targeted DEP® conjugate from its internal Targeted DEP® program resulted in tumour regression and 100% survival in a preclinical human ovarian cancer model. This finding builds on…

Next step in Alzheimer’s disease treatment – SVI & Janssen Pharmaceucticals Inc

29 August 2019 SVI has announced the extension of the research and licensing collaboration agreement with Janssen Pharmaceuticals, Inc, one of the Janssen Pharmaceutical Companies of Johnson & Johnson, with focus on Alzheimer’s disease treatment. The objective of…

Melbourne provides a spark for Israeli tech startup SparkBeyond

29 August 2019 Israeli tech startup company SparkBeyond has chosen Melbourne – Australia’s Tech City – for its first office in the country. Founded in 2013, SparkBeyond has built an artificial intelligence (AI) powered data analytics and problem…

The Australian PBS approves Mayne Pharma’s Kapanol morphine drug for reimbursement

29 August 2019 Mayne Pharma says the Australian Pharmaceutical Benefits Scheme has approved its Kapanol morphine drug for palliative care chronic breathlessness for reimbursement. Mayne Pharma said that from September 1, 2019 eligible palliative care patients taking 10mg…

Home

News & opinion

Member Directory

Events